Use of FDG-PET in differentiating benign from malignant compression fractures

Skeletal Radiology

Volumn 37, Issue 5, 2008, Pages 405-413

  Bredella, Miriam A ^a   Essary, Brendan ^a   Torriani, Martin ^a   Ouellette, Hugue A ^a   Palmer, William E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Benign; Compression fractures; FDG PET; Malignant; Spine

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM; IOPAMIDOL;

ADULT; AGED; ARTICLE; BONE CANCER; BONE TUMOR; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPRESSION FRACTURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; REFERENCE VALUE; RETROSPECTIVE STUDY; SPINE CANCER; SPINE TUMOR; STANDARD; STATISTICAL SIGNIFICANCE; STUDENT T TEST; VERTEBRA FRACTURE; WHOLE BODY PET;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; FRACTURES, COMPRESSION; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SPINAL FRACTURES; SPINAL NEOPLASMS; THORACIC VERTEBRAE;

EID: 43349100960     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-008-0452-5     Document Type: Article

References (20)

1. Fayad LM, Kamel IR, Kawamoto S, Bluemke DA, Frassica FJ, Fishman EK. Distinguishing stress fractures from pathologic fractures: a multimodality approach. Skeletal Radiol 2005; 34(5): 245-259.
2. Kubota T, Yamada K, Ito H, Kizu O, Nishimura T. High-resolution imaging of the spine using multidetector-row computed tomography: differentiation between benign and malignant vertebral compression fractures. J Comput Assist Tomogr 2005; 29(5): 712-719.
3. Uetani M, Hashmi R, Hayashi K. Malignant and benign compression fractures: differentiation and diagnostic pitfalls on MRI. Clin Radiol 2004; 59(2): 124-131.
4. Ho CS, Choi WM, Chen CY, Chen WY, Chan WP. Metastasis in vertebra mimicking acute compression fractures in a patient with osteoporosis: MRI findings. Clin Imaging 2005; 29(1): 64-67.
5. Li KC, Poon PY. Sensitivity and specificity of MRI in detecting malignant spinal cord compression and in distinguishing malignant from benign compression fractures of vertebrae. Magn Reson Imaging 1988; 6(5): 547-556.
6. Dehdashti F, Siegel BE, Griffeth LK, et al. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2- deoxy-D-glucose. Radiology 1996; 200(1): 243-247.
7. Glaspy JA, Hawkins R, Hoh CK, Phelps ME. Use of positron emission tomography in oncology. Oncology (Williston Park) 1993; 7(7): 41-46, 49-50.
8. Schmitz A, Risse JH, Textor J, et al. FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporos Int 2002; 13(9): 755-761.
9. Shon IH, Fogelman I. F-18 FDG positron emission tomography and benign fractures. Clin Nucl Med 2003; 28(3): 171-175.
10. Chan JH, Peh WC, Tsui EY, et al. Acute vertebral body compression fractures: discrimination between benign and malignant causes using apparent diffusion coefficients. Br J Radiol 2002; 75(891): 207-214.
11. Herneth AM, Phillip MO, Naude J, et al. Vertebral metastases: assessment with apparent diffusion coefficient. Radiology 2002; 225(3): 889-894.
12. Maeda M, Sakuma H, Maier SE, Takeda K. Quantitative assessment of diffusion abnormalities in benign and malignant vertebral compression fractures by line scan diffusion-weighted imaging. AJR Am J Roentgenol 2003; 181(5): 1203-1209.
13. Raya JG, Dietrich O, Reiser MF, Baur-Melnyk A. Methods and applications of diffusion imaging of vertebral bone marrow. J Magn Reson Imaging 2006; 24(6): 1207-1220.
14. Adler LP, Blair HF, Makley JT, et al. Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 1991; 32(8): 1508-1512.
15. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001; 219(3): 774-777.
16. Franzius C, Sciuk J, Daldrup-Link HE, Jürgens H, Schober J. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 2000; 27(9): 1305-1311.
17. Kazama T, Swanston N, Podoloff DA, Macapinlac H. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging 2005; 32(12): 1406-1411.
18. Masala S, Schillaci O, Massari F, et al. MRI and bone scan imaging in the preoperative evaluation of painful vertebral fractures treated with vertebroplasty and kyphoplasty. In Vivo 2005; 19(6): 1055-1060.
19. Guhlmann A, Brecht-Krauss D, Suger G, et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med 1998; 39(12): 2145-2152.
20. Guhlmann A, Brecht-Krauss D, Suger G, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 1998; 206(3): 749-754.